Meanwhile, based on the currently available data on COVID-19 patients, CCNB1 may also be used as a potential biomarker of COVID-19 in peripheral blood mononuclear cells (PBMCs), thereby contributing to the development of drugs for the treatment of COVID-19 disease [54]. The gene discussed is CCNB1; the disease is COVID-19.